Conflict of interest in medical research or clinical trial refers to situations where a patient’s health is compromised by either financial or non-financial gains. It is defined as a dispute between a physician’s decision in patient’s best interest, and any potential personal gain.
Concerns regarding the influence of biotechnology companies and pharmaceutical industries in research activities and funding of clinical trials have been increasing since the 1970’s. Conflict of interest arising from wide range of financial ties with the private industry leads to undue pressure on professional judgments and put the objectivity of professional education and the patient’s care and confidence in medicine at risk.
This bias may affect adverse events reporting, data analysis and interpretation. As such, there is a growing need to safeguard the interest of the human subjects and to protect their welfare while participating in research and clinical trials.
Table of Contents
1. Introduction
2. History
3. Types of conflict of interest:
3.1 Financial conflict of interest:
3.2 Investigator based conflict of interest:
3.3 Institutional based conflict of interest:
3.4 Institutional Review Board (IRB) based conflict of interest:
3.5 Conflict of interest in publication
4. Management of conflicts of interest:
5. Conclusion
Research Objectives and Core Themes
This paper examines the multifaceted nature of conflicts of interest within medical research and clinical trials, aiming to define how financial and non-financial pressures impact research integrity, patient safety, and public trust in scientific outcomes.
- Historical context of ethical breaches in clinical research.
- Categorization of financial conflicts involving investigators and institutions.
- The role and influence of Institutional Review Boards (IRBs).
- Non-financial conflicts related to academic publication and peer review.
- Strategies for the management and disclosure of conflicts of interest.
Excerpt from the Book
Introduction
Conflict of interest in medical research or clinical trial refers to situations where a patient’s health is compromised by either financial or non-financial gains. It is defined as a dispute between a physician’s decision in patient’s best interest, and any potential personal gain (Columbia University, 2004). Concerns regarding the influence of biotechnology companies and pharmaceutical industries in research activities and funding of clinical trials have been increasing since the 1970’s (Resnik, 2010). Conflict of interest arising from wide range of financial ties with the private industry leads to undue pressure on professional judgments and put the objectivity of professional education and the patient’s care and confidence in medicine at risk. This bias may affect adverse events reporting, data analysis and interpretation. As such, there is a growing need to safeguard the interest of the human subjects and to protect their welfare while participating in research and clinical trials (Lo and Fields, 2009).
Summary of Chapters
Introduction: Defines conflicts of interest in medical research and explains why rising industry influence necessitates safeguards to protect patient welfare and data integrity.
History: Reviews past ethical failures in clinical studies and the shift in the research landscape following the 1980 Bayh-Dole Act.
Types of conflict of interest:: Categorizes different conflict scenarios including financial, investigator-led, institutional, IRB-related, and publication-based conflicts.
Management of conflicts of interest:: Discusses mandatory disclosure policies and the need for independent oversight to maintain research credibility.
Conclusion: Highlights that while commercial influence in research is inevitable, stricter regulations and increased transparency are essential for the future of scientific trust.
Keywords
Conflict of Interest, Medical Research, Clinical Trials, Pharmaceutical Industry, Research Integrity, Informed Consent, Institutional Review Board, Disclosure, Bias, Patient Safety, Financial Ties, Biomedical Research, Data Concealment, Ethics, Professional Judgment.
Frequently Asked Questions
What is the core subject of this paper?
The paper explores the ethical and professional challenges posed by conflicts of interest in the medical research and clinical trial landscape.
What are the primary areas covered in the analysis?
It covers historical ethical violations, the classification of financial and institutional conflicts, the role of IRBs, and the impact of publication bias.
What is the main research objective?
The goal is to illustrate how financial and non-financial gains can distort medical research and to identify management strategies to safeguard research objectivity.
Which methodology is employed?
The paper utilizes a systematic review approach, synthesizing existing literature, historical case studies, and regulatory analysis.
What does the main body address?
It details the evolution of research regulation since the 1970s and examines specific risks associated with industry-sponsored research.
What characterizes this work?
The work is defined by its focus on transparency, regulatory compliance, and the protection of human subjects in clinical settings.
How did the Bayh-Dole Act change the research environment?
It allowed federally funded projects to be transferred to the private sector, significantly increasing the presence of commercial influence in academic research.
Why is IRB-based conflict of interest a critical concern?
Conflicts within IRBs are critical because these bodies are the primary gatekeepers for protecting participants; if they are incentivized by fees or equity, their ability to impartially review safety protocols is compromised.
- Citation du texte
- Anu Rastogi (Auteur), 2015, Conflict of Interest in Medical Research and Clinical Trials, Munich, GRIN Verlag, https://www.grin.com/document/321144
